Cindrova-Davies, T. & Sferruzzi-Perri, A. N. Human placental development and function. Semin. Cell Dev. Biol. 131, 66–77 (2022).
Burton, G. J. & Fowden, A. L. The placenta: a multifaceted, transient organ. Philos. Trans. R. Soc. B 370, 20140066 (2015).
Smith, G. C. S. First-trimester determination of complications of late pregnancy. JAMA 303, 561–562 (2010).
Brosens, I., Pijnenborg, R., Vercruysse, L. & Romero, R. The ‘great obstetrical syndromes’ are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204, 193–201 (2011). This study coined the phrase ‘great obstetrical syndromes’, which describe pregnancy complications rooted in deficient trophoblast invasion.
Hamilton, W. J. & Boyd, J. D. Development of the human placenta in the first three months of gestation. J. Anat. 94, 297–328 (1960).
Hertig, A. T., Rock, J. & Adams, E. C. A description of 34 human ova within the first 17 days of development. Am. J. Anat. 98, 435–493 (1956).
Pijnenborg, R., Dixon, G., Robertson, W. B. & Brosens, I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1, 3–19 (1980).
Burton, G. J., Jauniaux, E. & Watson, A. L. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181, 718–724 (1999).
Armingol, E., Officer, A., Harismendy, O. & Lewis, N. E. Deciphering cell-cell interactions and communication from gene expression. Nat. Rev. Genet. 22, 71–88 (2021).
Suryawanshi, H. et al. A single-cell survey of the human first-trimester placenta and decidua. Sci. Adv. 4, eaau4788 (2018).
Vento-Tormo, R. et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature 563, 347–353 (2018). This study was among the first to use single-cell transcriptomics to elucidate the cellular composition and interactions at the placental–decidual interface in early human pregnancy, identifying distinct immune cell subtypes (uNK1–uNK3 and uM1–uM3) and their predicted communication with trophoblast.
Tsang, J. C. H. et al. Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics. Proc. Natl Acad. Sci. USA 114, E7786–E7795 (2017).
Pique-Regi, R. et al. Single cell transcriptional signatures of the human placenta in term and preterm parturition. eLife 8, e52004 (2019).
Garcia-Flores, V. et al. Deciphering maternal-fetal cross-talk in the human placenta during parturition using single-cell RNA sequencing. Sci. Transl. Med. 16, eadh8335 (2024).
Liu, Y. et al. Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta. Cell Res. 28, 819–832 (2018).
Arutyunyan, A. et al. Spatial multiomics map of trophoblast development in early pregnancy. Nature 616, 143–151 (2023). This study presents a spatial multiomics dataset of implantation sites in early human pregnancy, uncovering the full trajectory of trophoblast differentiation and associated regulatory mechanisms.
Greenbaum, S. et al. A spatially resolved timeline of the human maternal-fetal interface. Nature 619, 595–605 (2023). This study used spatial proteomics and transcriptomics to profile the human placental–decidual interface across gestation, characterizing the cellular composition and interactions underlying both SAR and gestational progression.
Ounadjela, J. R. et al. Spatial multiomic landscape of the human placenta at molecular resolution. Nat. Med. 30, 3495–3508 (2024). This study provided a spatial reference of chromatin accessibility landscapes within first-trimester human placental villi at single-cell resolution, identifying genes under complex enhancer control (that is, domains of regulatory chromatin) and localizing them to discrete niches in the villi.
Wang, C. et al. Single-cell spatiotemporal dissection of the human maternal-fetal interface. Nature 653, 167–179 (2026). This study surveyed the human maternal–fetal interface across gestation, combining spatial transcriptomics and paired single-nucleus and chromatin accessibility profiling to identify and characterize new trophoblast, decidual stromal and decidual endothelial cell states.
Okae, H. et al. Derivation of human trophoblast stem cells. Cell Stem Cell 22, 50–63.e6 (2018). This landmark study derived hTSCs for the first time from both primary human placental villi and human blastocysts, and established robust protocols for their differentiation into SCTs and EVTs.
Haider, S. et al. Self-renewing trophoblast organoids recapitulate the developmental program of the early human placenta. Stem Cell Rep. 11, 537–551 (2018).
Turco, M. Y. et al. Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature 564, 263–267 (2018). This study provided one of the first robust protocols for deriving primary human trophoblast organoids and their subsequent differentiation into trophoblast subtypes (EVT).
Horii, M. et al. Modeling preeclampsia using human induced pluripotent stem cells. Sci. Rep. 11, 5877 (2021).
Hori, T. et al. Trophoblast stem cell-based organoid models of the human placental barrier. Nat. Commun. 15, 962 (2024).
Dong, C. et al. A genome-wide CRISPR-Cas9 knockout screen identifies essential and growth-restricting genes in human trophoblast stem cells. Nat. Commun. 13, 2548 (2022). This study used a CRISPR–Cas9-based screen in hTSCs to identify key regulators of trophoblast proliferation.
Muter, J., Lynch, V. J., McCoy, R. C. & Brosens, J. J. Human embryo implantation. Development 150, dev201507 (2023).
Turco, M. Y. & Moffett, A. Development of the human placenta. Development 146, dev163428 (2019).
Knöfler, M. et al. Human placenta and trophoblast development: key molecular mechanisms and model systems. Cell. Mol. Life Sci. 76, 3479–3496 (2019).
Molè, M. A., Weberling, A. & Zernicka-Goetz, M. Comparative analysis of human and mouse development: from zygote to pre-gastrulation. Curr. Top. Dev. Biol. 136, 113–138 (2020).
Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N. & Jauniaux, E. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 87, 2954–2959 (2002).
Demir, R. et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 25, 560–572 (2004).
Kayisli, U. A. et al. Spatial and temporal distribution of Tie-1 and Tie-2 during very early development of the human placenta. Placenta 27, 648–659 (2006).
Aplin, J. D. et al. Hemangioblastic foci in human first trimester placenta: distribution and gestational profile. Placenta 36, 1069–1077 (2015).
Huppertz, B. & Borges, M. Placenta trophoblast fusion. Methods Mol. Biol. 475, 135–147 (2008).
Baergen, R. N., Burton, G. J. & Kaplan, C. G. (eds). Benirschke’s Pathology of the Human Placenta https://doi.org/10.1007/978-3-030-84725-8 (Springer, 2021).
Burton, G. J. & Jauniaux, E. The cytotrophoblastic shell and complications of pregnancy. Placenta 60, 134–139 (2017).
Boyd, J. D. & Hamilton, W. J. Growth of placenta. In The Human Placenta 136–139 (Palgrave Macmillan, 1970).
Hustin, J. & Schaaps, J. P. Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am. J. Obstet. Gynecol. 157, 162–168 (1987).
Pijnenborg, R., Vercruysse, L. & Hanssens, M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27, 939–958 (2006).
Kam, E. P., Gardner, L., Loke, Y. W. & King, A. The role of trophoblast in the physiological change in decidual spiral arteries. Hum. Reprod. 14, 2131–2138 (1999).
Burton, G. J., Woods, A. W., Jauniaux, E. & Kingdom, J. C. P. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30, 473–482 (2009).
Jones, C. J. P. & Aplin, J. D. A re-examination of the origins of placental bed giant cells. Placenta 114, 39–41 (2021).
al-Lamki, R. S., Skepper, J. N. & Burton, G. J. Are human placental bed giant cells merely aggregates of small mononuclear trophoblast cells? An ultrastructural and immunocytochemical study. Hum. Reprod. 14, 496–504 (1999).
Castellucci, M., Kosanke, G., Verdenelli, F., Huppertz, B. & Kaufmann, P. Villous sprouting: fundamental mechanisms of human placental development. Hum. Reprod. Update 6, 485–494 (2000).
Petropoulos, S. et al. Single-cell RNA-seq reveals lineage and X chromosome dynamics in human preimplantation embryos. Cell 165, 1012–1026 (2016).
Yanagida, A. et al. Naive stem cell blastocyst model captures human embryo lineage segregation. Cell Stem Cell 28, 1016–1022.e4 (2021).
Meistermann, D. et al. Integrated pseudotime analysis of human pre-implantation embryo single-cell transcriptomes reveals the dynamics of lineage specification. Cell Stem Cell 28, 1625–1640.e6 (2021).
Xiang, L. et al. A developmental landscape of 3D-cultured human pre-gastrulation embryos. Nature 577, 537–542 (2020).
Zhao, C. et al. A comprehensive human embryo reference tool using single-cell RNA-sequencing data. Nat. Methods 22, 193–206 (2025). This is an integrated reference dataset for human embryo development spanning pre-implantation to post-implantation stages.
Saha, B. et al. TEAD4 ensures postimplantation development by promoting trophoblast self-renewal: an implication in early human pregnancy loss. Proc. Natl Acad. Sci. USA 117, 17864–17875 (2020).
Meinhardt, G. et al. Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta. Proc. Natl Acad. Sci. USA 117, 13562–13570 (2020).
Papuchova, H. & Latos, P. A. Transcription factor networks in trophoblast development. Cell. Mol. Life Sci. 79, 337 (2022).
Aplin, J. D. & Jones, C. J. P. Cell dynamics in human villous trophoblast. Hum. Reprod. Update 27, 904–922 (2021).
Ng, R. K. et al. Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5. Nat. Cell Biol. 10, 1280–1290 (2008).
Hemberger, M., Udayashankar, R., Tesar, P., Moore, H. & Burton, G. J. ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Hum. Mol. Genet. 19, 2456–2467 (2010).
Soncin, F. et al. Comparative analysis of mouse and human placentae across gestation reveals species-specific regulators of placental development. Development 145, dev156273 (2018).
Calderon, R. I. et al. VGLL1 contributes to both the transcriptome and epigenome of the developing trophoblast compartment. Proc. Natl Acad. Sci. USA 122, e2508432122 (2025).
Gerri, C. et al. Initiation of a conserved trophectoderm program in human, cow and mouse embryos. Nature 587, 443–447 (2020).
Hornbachner, R. et al. MSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cells. Proc. Natl Acad. Sci. USA 118, e2105130118 (2021).
Li, Y., Moretto-Zita, M., Leon-Garcia, S. & Parast, M. M. P63 inhibits extravillous trophoblast migration and maintains cells in a cytotrophoblast stem cell-like state. Am. J. Pathol. 184, 3332–3343 (2014).
Li, W.-F. et al. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53. Acta Pharmacol. Sin. 42, 1888–1899 (2021).
Costa, M. A. The endocrine function of human placenta: an overview. Reprod. Biomed. Online 32, 14–43 (2016).
Renaud, S. J. & Jeyarajah, M. J. How trophoblasts fuse: an in-depth look into placental syncytiotrophoblast formation. Cell. Mol. Life Sci. 79, 433 (2022).
Burton, G. J. & Watson, A. L. The structure of the human placenta: implications for initiating and defending against virus infections. Rev. Med. Virol. 7, 219–228 (1997).
Wang, M. et al. Single-nucleus multi-omic profiling of human placental syncytiotrophoblasts identifies cellular trajectories during pregnancy. Nat. Genet. 56, 294–305 (2024). This study used single-nucleus transcriptomics and chromatin accessibility profiling to characterize distinct SCT subtype transitions, and associated regulatory programmes, across human pregnancy.
Petrany, M. J. et al. Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers. Nat. Commun. 11, 6374 (2020).
Chuong, E. B., Rumi, M. A. K., Soares, M. J. & Baker, J. C. Endogenous retroviruses function as species-specific enhancer elements in the placenta. Nat. Genet. 45, 325–329 (2013).
Todd, C. D., Deniz, Ö, Taylor, D. & Branco, M. R. Functional evaluation of transposable elements as enhancers in mouse embryonic and trophoblast stem cells. eLife 8, e44344 (2019).
Frost, J. M. et al. Regulation of human trophoblast gene expression by endogenous retroviruses. Nat. Struct. Mol. Biol. 30, 527–538 (2023).
Fueyo, R. et al. A human-specific regulatory mechanism revealed in a pre-implantation model. Nature 647, 238–247 (2025).
Anwar, R. et al. ERV3-MLT1 provides cis-regulatory elements for human placental functioning and are commonly dysregulated in human-specific preeclampsia. Genome Biol. 26, 364 (2025).
Keighley, L. M., Lynch-Sutherland, C. F., Almomani, S. N., Eccles, M. R. & Macaulay, E. C. Unveiling the hidden players: the crucial role of transposable elements in the placenta and their potential contribution to pre-eclampsia. Placenta 141, 57–64 (2023).
Štafl, K. et al. Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta. Proc. Natl Acad. Sci. USA 121, e2407519121 (2024).
Soygur, B. & Sati, L. The role of syncytins in human reproduction and reproductive organ cancers. Reproduction 152, R167–R178 (2016).
Cesana, M. et al. TFEB controls syncytiotrophoblast formation and hormone production in placenta. Cell Death Differ. 31, 1439–1451 (2024).
Zheng, W. et al. TFEB safeguards trophoblast syncytialization in humans and mice. Proc. Natl Acad. Sci. USA 121, e2404062121 (2024).
Liang, C.-Y. et al. GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta. Biol. Reprod. 83, 387–395 (2010).
Karlsson, M. et al. A single-cell type transcriptomics map of human tissues. Sci. Adv. 7, eabh2169 (2021).
Cinkornpumin, J. K. et al. Hypoxia and loss of GCM1 expression prevent differentiation and contact inhibition in human trophoblast stem cells. Stem Cell Rep. 20, 102481 (2025).
Genbacev, O., Zhou, Y., Ludlow, J. W. & Fisher, S. J. Regulation of human placental development by oxygen tension. Science 277, 1669–1672 (1997).
Burton, G. J., Cindrova-Davies, T., Yung, H. W. & Jauniaux, E. Hypoxia and reproductive health: oxygen and development of the human placenta. Reproduction 161, F53–F65 (2021).
Kopriva, S. E., Chiasson, V. L., Mitchell, B. M. & Chatterjee, P. TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4 pathway. PLoS ONE 8, e67760 (2013).
Monget, P. & Oxvig, C. PAPP-A and the IGF system. Ann. Endocrinol. 77, 90–96 (2016).
Cristodoro, M. et al. First trimester placental biomarkers for pregnancy outcomes. Int. J. Mol. Sci. 25, 6136 (2024).
Mayhew, T. M. A stereological perspective on placental morphology in normal and complicated pregnancies. J. Anat. 215, 77–90 (2009).
Männik, J., Vaas, P., Rull, K., Teesalu, P. & Laan, M. Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus. Mol. Cell. Endocrinol. 355, 180–187 (2012).
Männik, J. et al. Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J. Clin. Endocrinol. Metab. 95, 2433–2442 (2010).
Freemark, M. Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Horm. Res. 65, 41–49 (2006).
Napso, T., Yong, H. E. J., Lopez-Tello, J. & Sferruzzi-Perri, A. N. The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation. Front. Physiol. 9, 1091 (2018).
Walker, V. The molecular biology of placental transport of calcium to the human foetus. Int. J. Mol. Sci. 26, 383 (2025).
Loukeris, K., Sela, R. & Baergen, R. N. Syncytial knots as a reflection of placental maturity: reference values for 20 to 40 weeks’ gestational age. Pediatr. Dev. Pathol. 13, 305–309 (2010).
Fogarty, N. M. E., Ferguson-Smith, A. C. & Burton, G. J. Syncytial knots (Tenney-Parker changes) in the human placenta: evidence of loss of transcriptional activity and oxidative damage. Am. J. Pathol. 183, 144–152 (2013).
Bierens, J. et al. Imaging and quantification of placental terminal villi microvasculature and nuclear characteristics in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 308, 181–189 (2025).
Luo, Y. et al. Clinical and pathological characteristics of gestational diabetes mellitus with different insulin resistance. J. Diabetes Complications 38, 108796 (2024).
Bhanarkar, U. & Potdar, P. A cross-sectional study comparing placental characteristics in pregnancy-induced hypertension and sickle cell anaemia. Cureus 16, e70034 (2024).
Barak, Y. et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4, 585–595 (1999).
Ruebner, M. et al. Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis. J. Cell. Biochem. 113, 2383–2396 (2012).
Armistead, B. et al. Induction of the PPARγ (peroxisome proliferator-activated receptor γ)-GCM1 (glial cell missing 1) syncytialization axis reduces sFLT1 (soluble fms-like tyrosine kinase 1) in the preeclamptic placenta. Hypertension 78, 230–240 (2021).
Chen, Z. et al. PPARγ stimulates expression of L-type amino acid and taurine transporters in human placentas: the evidence of PPARγ regulating fetal growth. Sci. Rep. 5, 12650 (2015).
Gaccioli, F. et al. Expression and functional characterisation of System L amino acid transporters in the human term placenta. Reprod. Biol. Endocrinol. 13, 57 (2015).
Ohgaki, R. et al. Essential roles of L-type amino acid transporter 1 in syncytiotrophoblast development by presenting fusogenic 4F2hc. Mol. Cell. Biol. 37, e00427–16 (2017).
Kudo, Y., Boyd, C. A. R., Millo, J., Sargent, I. L. & Redman, C. W. G. Manipulation of CD98 expression affects both trophoblast cell fusion and amino acid transport activity during syncytialization of human placental BeWo cells. J. Physiol. 550, 3–9 (2003).
He, P. et al. Reduced expression of 11β-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARγ but increased PPARα expression. Endocrinology 155, 299–309 (2014).
Granitzer, S. et al. LAT1-NRF2 axis controls sFlt-1/PlGF imbalance and oxidative stress in preeclampsia. Nat. Commun. 16, 9112 (2025).
Guo, Q., Choi, J., Lee, M. & Kim, J. PPARG-centric transcriptional re-wiring during differentiation of human trophoblast stem cells into extravillous trophoblasts. Nucleic Acids Res. 53, gkaf669 (2025).
Keenen, M. M. et al. Comparative analysis of the syncytiotrophoblast in placenta tissue and trophoblast organoids using snRNA sequencing. eLife 13, RP101170 (2025).
Pierleoni, C., Castellucci, M., Kaufmann, P., Lund, L. R. & Schnack Nielsen, B. Urokinase receptor is up-regulated in endothelial cells and macrophages associated with fibrinoid deposits in the human placenta. Placenta 24, 677–685 (2003).
Thomas, J. R. et al. Phenotypic and functional characterization of first-trimester human placental macrophages, Hofbauer cells. J. Exp. Med. 218, e20200891 (2021).
Jauniaux, E. & Jurkovic, D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta 33, 244–251 (2012).
Garrido-Gomez, T. et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc. Natl Acad. Sci. USA 114, E8468–E8477 (2017).
Lee, C. Q. E. et al. Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta. Development 145, dev162305 (2018).
Damsky, C. H. et al. Integrin switching regulates normal trophoblast invasion. Development 120, 3657–3666 (1994).
Dietrich, B., Haider, S., Meinhardt, G., Pollheimer, J. & Knöfler, M. WNT and NOTCH signaling in human trophoblast development and differentiation. Cell. Mol. Life Sci. 79, 292 (2022).
Haider, S. et al. Notch1 controls development of the extravillous trophoblast lineage in the human placenta. Proc. Natl Acad. Sci. USA 113, E7710–E7719 (2016).
Meinhardt, G. et al. The multifaceted roles of the transcriptional coactivator TAZ in extravillous trophoblast development of the human placenta. Proc. Natl Acad. Sci. USA 122, e2426385122 (2025).
Gu, B. et al. The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts. Proc. Natl Acad. Sci. USA 122, e2425339122 (2025).
Ghosh, A. et al. The GATA transcriptional program dictates cell fate equilibrium to establish the maternal-fetal exchange interface and fetal development. Proc. Natl Acad. Sci. USA 121, e2310502121 (2024).
Varberg, K. M. et al. Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. Nat. Commun. 14, 4826 (2023).
Kim, M. et al. The transcriptional regulatory network modulating human trophoblast stem cells to extravillous trophoblast differentiation. Nat. Commun. 15, 1285 (2024).
Shukla, V. et al. NOTUM-mediated WNT silencing drives extravillous trophoblast cell lineage development. Proc. Natl Acad. Sci. USA 121, e2403003121 (2024).
Kakugawa, S. et al. Notum deacylates Wnt proteins to suppress signalling activity. Nature 519, 187–192 (2015).
Dietrich, B. et al. NOTCH3 signalling controls human trophoblast stem cell expansion and differentiation. Development 150, dev202152 (2023).
Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014).
Haider, S. et al. Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta. Proc. Natl Acad. Sci. USA 119, e2120667119 (2022). This study explores the role of TGFβ signalling in generating higher-fidelity invasive EVTs in vitro.
Perez-Garcia, V. et al. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion. eLife 10, e63254 (2021).
Thompson, E. W. et al. EMT and cancer: what clinicians should know. Nat. Rev. Clin. Oncol. 22, 711–733 (2025).
Zhang, D. et al. ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer. Oncogene 42, 2841–2853 (2023).
Kong, S.-Y. et al. The ELK3-GATA3 axis orchestrates invasion and metastasis of breast cancer cells in vitro and in vivo. Oncotarget 7, 65137–65146 (2016).
He, Y. et al. EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer. Cell Death Dis. 12, 430 (2021).
Wakeland, A. K. et al. Hypoxia directs human extravillous trophoblast differentiation in a hypoxia-inducible factor-dependent manner. Am. J. Pathol. 187, 767–780 (2017).
Treissman, J. et al. Low oxygen enhances trophoblast column growth by potentiating differentiation of the extravillous lineage and promoting LOX activity. Development 147, dev181263 (2020).
Zhou, Y. et al. LIMK1 regulates human trophoblast invasion/differentiation and is down-regulated in preeclampsia. Am. J. Pathol. 184, 3321–3331 (2014).
Genbacev, O., Joslin, R., Damsky, C. H., Polliotti, B. M. & Fisher, S. J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest. 97, 540–550 (1996).
Cowden Dahl, K. D. et al. Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol. Cell. Biol. 25, 10479–10491 (2005).
Maltepe, E. et al. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development 132, 3393–3403 (2005).
Pijnenborg, R. & Vercruysse, L. Animal models of deep trophoblast invasion. In Placental Bed Disorders (eds Pijnenborg, R. et al.) 127–139 https://doi.org/10.1017/cbo9780511750847.014 (Cambridge Univ. Press, 2010).
Renaud, S. J., Kubota, K., Rumi, M. A. K. & Soares, M. J. The FOS transcription factor family differentially controls trophoblast migration and invasion. J. Biol. Chem. 289, 5025–5039 (2014).
Moffett, A. & Shreeve, N. Local immune recognition of trophoblast in early human pregnancy: controversies and questions. Nat. Rev. Immunol. 23, 222–235 (2023).
Papuchova, H. et al. Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties. Proc. Natl Acad. Sci. USA 117, 15772–15777 (2020).
Brosens, I., Robertson, W. B. & Dixon, H. G. The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93, 569–579 (1967).
Wiedemann, E. et al. Regulation of endothelial migration and proliferation by ephrin-A1. Cell. Signal. 29, 84–95 (2017).
Jerafi-Vider, A. et al. VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells. Cell Rep. 35, 109255 (2021).
Fagiani, E. & Christofori, G. Angiopoietins in angiogenesis. Cancer Lett. 328, 18–26 (2013).
Gonçalves Silva, I. et al. The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells. eBioMedicine 22, 44–57 (2017).
Wilkens, J. et al. Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J. Immunol. 191, 2226–2235 (2013).
Choudhury, R. H. et al. Decidual leucocytes infiltrating human spiral arterioles are rich source of matrix metalloproteinases and degrade extracellular matrix in vitro and in situ. Am. J. Reprod. Immunol. 81, e13054 (2019).
Hazan, A. D. et al. Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am. J. Pathol. 177, 1017–1030 (2010).
Robson, A. et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 26, 4876–4885 (2012).
Fraser, R., Whitley, G. S. J., Thilaganathan, B. & Cartwright, J. E. Decidual natural killer cells regulate vessel stability: implications for impaired spiral artery remodelling. J. Reprod. Immunol. 110, 54–60 (2015).
Puig-Gámez, M., Van Attekum, M., Theis, T., Dick, A. & Park, J. E. Transcriptional signature of rapidly responding NK cells reveals S1P5 and CXCR4 as anti-tumor response disruptors. Sci. Rep. 15, 10769 (2025).
Lee, E. et al. CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis. Nat. Commun. 16, 4854 (2025).
Solano, M. E. Decidual immune cells: guardians of human pregnancies. Best Pract. Res. Clin. Obstet. Gynaecol. 60, 3–16 (2019).
Vondra, S. et al. The human placenta shapes the phenotype of decidual macrophages. Cell Rep. 42, 112285 (2023).
Huhn, O. et al. Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy. Nat. Commun. 11, 381 (2020).
Hiby, S. E. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957–965 (2004). This haplotype association study linked maternal KIR genotype AA, when paired with fetal HLA-C2, with a higher risk of pre-eclampsia.
Hamilton, G. S., Lysiak, J. J., Watson, A. J. & Lala, P. K. Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J. Endocrinol. 159, 69–77 (1998).
Sato, Y. et al. Trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards invasive phenotype. Development 130, 5519–5532 (2003).
Li, Q. et al. Human uterine natural killer cells regulate differentiation of extravillous trophoblast early in pregnancy. Cell Stem Cell 31, 181–195.e9 (2024). This study functionally validated the role of uNK-derived cytokines in modulating trophoblast invasion.
Hegde, U. C. Immunomodulation of the mother during pregnancy. Med. Hypotheses 35, 159–164 (1991).
Li, W.-X., Xu, X.-H. & Jin, L.-P. Regulation of the innate immune cells during pregnancy: an immune checkpoint perspective. J. Cell. Mol. Med. 25, 10362–10375 (2021).
Deer, E. et al. The role of immune cells and mediators in preeclampsia. Nat. Rev. Nephrol. 19, 257–270 (2023).
Arenas-Hernandez, M. et al. Effector and activated T cells induce preterm labor and birth that is prevented by treatment with progesterone. J. Immunol. 202, 2585–2608 (2019).
Cai, J. & Li, Q. Mendelian randomization analysis of the causal links between immune cells, metabolites, and ectopic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 316, 114797 (2026).
Apps, R. et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26–39 (2009).
Lee, C. Q. E. et al. What is trophoblast? A combination of criteria define human first-trimester trophoblast. Stem Cell Rep. 6, 257–272 (2016). This paper proposed a framework consisting of four criteria that together define the identity of first-trimester human trophoblasts.
Petroff, M. G. et al. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 68, 1496–1504 (2003).
Kovats, S. et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248, 220–223 (1990).
King, A. et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30, 1623–1631 (2000).
Loke, Y. W. & King, A. Immunology of implantation. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14, 827–837 (2000).
Apps, R., Gardner, L., Sharkey, A. M., Holmes, N. & Moffett, A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 37, 1924–1937 (2007).
King, A., Birkby, C. & Loke, Y. W. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell. Immunol. 118, 337–344 (1989).
Pitts, H. A. et al. SPINK2 protein expression is an independent adverse prognostic marker in AML and is potentially implicated in the regulation of ferroptosis and immune response. Int. J. Mol. Sci. 24, 9696 (2023).
Han, P.-F. et al. Annexin A1 involved in the regulation of inflammation and cell signaling pathways. Chin. J. Traumatol. 23, 96–101 (2020).
Takenaka, M. C., Robson, S. & Quintana, F. J. Regulation of the T cell response by CD39. Trends Immunol. 37, 427–439 (2016).
Bouariu, A., Panaitescu, A. M. & Nicolaides, K. H. First trimester prediction of adverse pregnancy outcomes-identifying pregnancies at risk from as early as 11-13 weeks. Medicina 58, 332 (2022).
Dimitriadis, E. et al. Pre-eclampsia. Nat. Rev. Dis. Primers 9, 8 (2023).
Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341–354 (2021).
Hiby, S. E. et al. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23, 972–976 (2008).
Hiby, S. E. et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J. Immunol. 192, 5069–5073 (2014).
Tyrmi, J. S. et al. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol. 8, 674–683 (2023).
Pujol Gualdo, N. et al. Atlas of genetic and phenotypic associations across 42 female reproductive health diagnoses. Nat. Med. 31, 1626–1634 (2025). This study provided a meta-analysis of GWAS results for various reproductive disorders, describing genetic risk factors implicated in reproductive development and function.
Manokhina, I., Wilson, S. L. & Robinson, W. P. Noninvasive nucleic acid-based approaches to monitor placental health and predict pregnancy-related complications. Am. J. Obstet. Gynecol. 213, S197–S206 (2015).
Moufarrej, M. N. et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature 602, 689–694 (2022). This study identified cell-free RNA signatures that may serve as early predictors of pre-eclampsia.
De Borre, M. et al. Cell-free DNA methylome analysis for early preeclampsia prediction. Nat. Med. 29, 2206–2215 (2023).
Adil, M. et al. Preeclampsia risk prediction from prenatal cell-free DNA screening. Nat. Med. 31, 1312–1318 (2025).
Elovitz, M. A. et al. Molecular subtyping of hypertensive disorders of pregnancy. Nat. Commun. 16, 2948 (2025).
Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649–658 (2003).
Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672–683 (2004).
Zeisler, H. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374, 13–22 (2016).
Miller, J. J. et al. Clinical validation of the sFlt-1:PlGF ratio as a biomarker for preeclampsia diagnosis in a high-risk obstetrics unit. J. Appl. Lab. Med. 8, 457–468 (2023).
Gaccioli, F., Lager, S., Sovio, U., Charnock-Jones, D. S. & Smith, G. C. S. The pregnancy outcome prediction (POP) study: investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes. Placenta 59, S17–S25 (2017).
Kariori, M., Katsi, V. & Tsioufis, C. Late vs early preeclampsia. Int. J. Mol. Sci. 26, 11091 (2025).
Hiby, S. E. et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 120, 4102–4110 (2010).
Gil Laborda, R. et al. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure. Sci. Rep. 14, 3354 (2024).
Xiong, S. et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J. Clin. Invest. 123, 4264–4272 (2013).
Kennedy, P. R. et al. Activating KIR2DS4 is expressed by uterine NK cells and contributes to successful pregnancy. J. Immunol. 197, 4292–4300 (2016).
Redman, C. W. G., Staff, A. C. & Roberts, J. M. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am. J. Obstet. Gynecol. 226, S907–S927 (2022).
Guller, S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb. Res. 124, 389–392 (2009).
Aplin, J. D., Myers, J. E., Timms, K. & Westwood, M. Tracking placental development in health and disease. Nat. Rev. Endocrinol. 16, 479–494 (2020).
McGinnis, R. et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat. Genet. 49, 1255–1260 (2017).
Mack, J. A. et al. Genetic variants associated with preeclampsia and maternal serum sFLT1 levels. Hypertension 82, 839–848 (2025).
Admati, I. et al. Two distinct molecular faces of preeclampsia revealed by single-cell transcriptomics. Med 4, 687–709.e7 (2023).
Granger, J. P., Alexander, B. T., Llinas, M. T., Bennett, W. A. & Khalil, R. A. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9, 147–160 (2002).
Li, H., Gu, B., Zhang, Y., Lewis, D. F. & Wang, Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 26, 210–217 (2005).
Fuenzalida, B. et al. Primary human trophoblasts mimic the preeclampsia phenotype after acute hypoxia-reoxygenation insult. Cells 11, 1898 (2022).
Ma, J. et al. The diversity of trophoblast cells and niches of placenta accreta spectrum disorders revealed by single-cell RNA sequencing. Front. Cell Dev. Biol. 10, 1044198 (2022).
Afshar, Y. et al. Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium. Am. J. Obstet. Gynecol. 230, 443.e1–443.e18 (2024).
Ji, K. et al. Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders. Biomark. Res. 12, 55 (2024).
Gingrich, J., Ticiani, E. & Veiga-Lopez, A. Placenta disrupted: endocrine disrupting chemicals and pregnancy. Trends Endocrinol. Metab. 31, 508–524 (2020).
Mathiesen, L., Sandal, D., Hammer, I. E. M., Styrishave, B. & Knudsen, L. E. Models of endocrine-disrupting effects: human placental steroidogenesis. Basic Clin. Pharmacol. Toxicol. 137, e70073 (2025).
Armingol, E. et al. Atlas-scale metabolic activities inferred from single-cell and spatial transcriptomics. Preprint at bioRxiv https://doi.org/10.1101/2025.05.09.653038 (2025).
Wagner, A. et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell 184, 4168–4185.e21 (2021).
Maizels, R. J. & Briscoe, J. Gene regulatory networks: from correlative models to causal explanations. Nat. Rev. Genet. 27, 485–498 (2026).
Karvas, R. M. et al. Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens. Cell Stem Cell 29, 810–825.e8 (2022).
Schwarz, L. C. et al. A blastocyst-derived in vitro model of the human chorion. Preprint at bioRxiv https://doi.org/10.1101/2025.08.06.668884 (2025).
Shannon, M. J. et al. Single-cell assessment of primary and stem cell-derived human trophoblast organoids as placenta-modeling platforms. Dev. Cell 59, 776–792.e11 (2024). This study benchmarks trophoblast organoid models from different origins (stem cells versus primary) using single-cell transcriptomics.
Sheridan, M. A. et al. Characterization of primary models of human trophoblast. Development 148, dev199749 (2021).
Hoo, R. et al. Acute response to pathogens in the early human placenta at single-cell resolution. Cell Syst. 15, 425–444.e9 (2024).
Turco, M. Y. et al. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat. Cell Biol. 19, 568–577 (2017).
Boretto, M. et al. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development 144, 1775–1786 (2017).
Boretto, M. et al. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nat. Cell Biol. 21, 1041–1051 (2019).
Gnecco, J. S. et al. Organoid co-culture model of the human endometrium in a fully synthetic extracellular matrix enables the study of epithelial-stromal crosstalk. Med 4, 554–579.e9 (2023).
Rawlings, T. M. et al. Modelling the impact of decidual senescence on embryo implantation in human endometrial assembloids. eLife 10, e69603 (2021).
Yu, L. et al. Large-scale production of human blastoids amenable to modeling blastocyst development and maternal-fetal cross talk. Cell Stem Cell 30, 1246–1261.e9 (2023).
Kagawa, H. et al. Human blastoids model blastocyst development and implantation. Nature 601, 600–605 (2022).
Shibata, S. et al. Modeling embryo-endometrial interface recapitulating human embryo implantation. Sci. Adv. 10, eadi4819 (2024). This study developed a multicellular in vitro 3D platform encompassing endometrial epithelial, stromal and endothelial compartments that recapitulate key stages of human embryo implantation.
Molè, M. A. et al. Modeling human embryo implantation in vitro. Cell 189, 87–105.e28 (2026). This study recently developed a bi-compartmentalized scaffold containing endometrial epithelial and stromal cells that resemble key features of endometrial tissue architecture (for example, invaginating glands), which is permissive to human embryo implantation.
Li, Q. et al. A 3D in vitro model for studying human implantation and implantation failure. Cell 189, 70–86.e20 (2026).
Liu, L. et al. Modeling post-implantation stages of human development into early organogenesis with stem-cell-derived peri-gastruloids. Cell 186, 3776–3792.e16 (2023).
Simoni, M. K. et al. Type I interferon exposure of an implantation-on-a-chip device alters invasive extravillous trophoblast function. Cell Rep. Med. 6, 101991 (2025).
Park, J. Y. et al. A microphysiological model of human trophoblast invasion during implantation. Nat. Commun. 13, 1252 (2022).
Kim, S. W., Genceroglu, A. & Kim, J. Patient-specific trophoblast stem cells for placental medicine. Trends Mol. Med. https://doi.org/10.1016/j.molmed.2026.02.009 (2026).
Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076–1100 (2024).
Shimizu, T. et al. CRISPR screening in human trophoblast stem cells reveals both shared and distinct aspects of human and mouse placental development. Proc. Natl Acad. Sci. USA 120, e2311372120 (2023). The second CRISPR–Cas9-based screen in hTSCs, identifying key regulators driving the acquisition of specific trophoblast fates (SCT and EVT).
Rood, J. E. et al. The Human Cell Atlas from a cell census to a unified foundation model. Nature 637, 1065–1071 (2025).
Bahrami, M., Richter, T., Schmacke, N. A., Egea Lavandera, A. & Theis, F. J. From modality-specific to compositional foundation models for cell biology. Cell Syst. 17, 101534 (2026).
Cui, H. et al. Towards multimodal foundation models in molecular cell biology. Nature 640, 623–633 (2025).
Genbacev, O., Schubach, S. A. & Miller, R. K. Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 13, 439–461 (1992).
Newby, D., Marks, L., Cousins, F., Duffie, E. & Lyall, F. Villous explant culture: characterization and evaluation of a model to study trophoblast invasion. Hypertens. Pregnancy 24, 75–91 (2005).
Sooranna, S. R., Oteng-Ntim, E., Meah, R., Ryder, T. A. & Bajoria, R. Characterization of human placental explants: morphological, biochemical and physiological studies using first and third trimester placenta. Hum. Reprod. 14, 536–541 (1999).
James, J. L., Stone, P. R. & Chamley, L. W. Cytotrophoblast differentiation in the first trimester of pregnancy: evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast. Reproduction 130, 95–103 (2005).
Seeho, S. K. M., Park, J. H., Rowe, J., Morris, J. M. & Gallery, E. D. M. Villous explant culture using early gestation tissue from ongoing pregnancies with known normal outcomes: the effect of oxygen on trophoblast outgrowth and migration. Hum. Reprod. 23, 1170–1179 (2008).
Miller, R. K. et al. Human placental explants in culture: approaches and assessments. Placenta 26, 439–448 (2005).
Li, X., Li, Z.-H., Wang, Y.-X. & Liu, T.-H. A comprehensive review of human trophoblast fusion models: recent developments and challenges. Cell Death Discov. 9, 372 (2023).
Kliman, H. J., Nestler, J. E., Sermasi, E., Sanger, J. M. & Strauss, J. F. 3rd. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118, 1567–1582 (1986).
Zhou, Y. et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest. 99, 2139–2151 (1997).
Douglas, G. C. & King, B. F. Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J. Immunol. Methods 119, 259–268 (1989).
Librach, C. L. et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113, 437–449 (1991).
Pattillo, R. A., Gey, G. O., Delfs, E. & Mattingly, R. F. Human hormone production in vitro. Science 159, 1467–1469 (1968).
Pattillo, R. A. et al. The hormone-synthesizing trophoblastic cell in vitro: a model for cancer research and placental hormone synthesis. Ann. N. Y. Acad. Sci. 172, 288–298 (1971).
Kohler, P. O. & Bridson, W. E. Isolation of hormone-producing clonal lines of human choriocarcinoma. J. Clin. Endocrinol. Metab. 32, 683–687 (1971).
Rothbauer, M. et al. A comparative study of five physiological key parameters between four different human trophoblast-derived cell lines. Sci. Rep. 7, 5892 (2017).
McConkey, C. A. et al. A three-dimensional culture system recapitulates placental syncytiotrophoblast development and microbial resistance. Sci. Adv. 2, e1501462 (2016).
Pastuschek, J. et al. Molecular characteristics of established trophoblast-derived cell lines. Placenta 108, 122–133 (2021).
Yin, E. & Esbin, M. N. Optimized CRISPR-based knockout in BeWo cells. Placenta 166, 71–76 (2025).
Graham, C. H. et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206, 204–211 (1993).
Hannan, N. J., Paiva, P., Dimitriadis, E. & Salamonsen, L. A. Models for study of human embryo implantation: choice of cell lines? Biol. Reprod. 82, 235–245 (2010).
Kilburn, B. A. et al. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol. Reprod. 62, 739–747 (2000).
LaMarca, H. L. et al. Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion. Placenta 26, 709–720 (2005).
Abou-Kheir, W., Barrak, J., Hadadeh, O. & Daoud, G. HTR-8/SVneo cell line contains a mixed population of cells. Placenta 50, 1–7 (2017).
Chen, Y., Siriwardena, D., Penfold, C., Pavlinek, A. & Boroviak, T. E. An integrated atlas of human placental development delineates essential regulators of trophoblast stem cells. Development 149, dev200171 (2022).
Lea, G. et al. Ectopic expression of DNMT3L in human trophoblast stem cells restores features of the placental methylome. Cell Stem Cell 32, 276–292.e9 (2025).
Shannon, M. J. et al. Cell trajectory modeling identifies a primitive trophoblast state defined by BCAM enrichment. Development 149, dev199840 (2022).
Varberg, K. M. et al. Leveraging chorionic villus biopsies for the derivation of patient-specific trophoblast stem cells. Commun. Biol. 8, 964 (2025).
Wang, L.-J. et al. Functional antagonism between ΔNp63α and GCM1 regulates human trophoblast stemness and differentiation. Nat. Commun. 13, 1626 (2022).
Karakis, V., Britt, J. W., Jabeen, M., San Miguel, A. & Rao, B. M. Derivation of human trophoblast stem cells from placentas at birth. J. Biol. Chem. 301, 108505 (2025).
Naama, M. et al. Pluripotency-independent induction of human trophoblast stem cells from fibroblasts. Nat. Commun. 14, 3359 (2023).
Dong, C. et al. Derivation of trophoblast stem cells from naïve human pluripotent stem cells. eLife 9, e52504 (2020).
Castel, G. et al. Induction of human trophoblast stem cells from somatic cells and pluripotent stem cells. Cell Rep. 33, 108419 (2020).
Cinkornpumin, J. K. et al. Naive human embryonic stem cells can give rise to cells with a trophoblast-like transcriptome and methylome. Stem Cell Rep. 15, 198–213 (2020).
Io, S. et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell Stem Cell 28, 1023–1039.e13 (2021).
Morey, R. et al. iPSC-based modeling of preeclampsia identifies epigenetic defects in extravillous trophoblast differentiation. iScience 27, 109569 (2024).
Liu, X. et al. Reprogramming roadmap reveals route to human induced trophoblast stem cells. Nature 586, 101–107 (2020).
Yang, L., Liang, P., Yang, H. & Coyne, C. B. Trophoblast organoids with physiological polarity model placental structure and function. J. Cell Sci. 137, jcs261528 (2024).
Smith, S. D., Dunk, C. E., Aplin, J. D., Harris, L. K. & Jones, R. L. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am. J. Pathol. 174, 1959–1971 (2009).
Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24, 494–515 (2023).
Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).
Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e15 (2018).
Marco Salas, S. et al. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows. Nat. Methods 22, 813–823 (2025).
Rodriques, S. G. et al. Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution. Science 363, 1463–1467 (2019).
Stickels, R. R. et al. Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2. Nat. Biotechnol. 39, 313–319 (2021).
Russell, A. J. C. et al. Slide-tags enables single-nucleus barcoding for multimodal spatial genomics. Nature 625, 101–109 (2024).
Oliveira, M. F. de et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat. Genet. 57, 1512–1523 (2025).
Zhou, F. et al. Reconstituting the transcriptome and DNA methylome landscapes of human implantation. Nature 572, 660–664 (2019).
Wang, Y. et al. A single-cell characterization of human post-implantation embryos cultured in vitro delineates morphogenesis in primary syncytialization. Front. Cell Dev. Biol. 10, 835445 (2022).
d’Hauterive, S. P. et al. Human chorionic gonadotropin and early embryogenesis: review. Int. J. Mol. Sci. 23, 1380 (2022).
Chen, P. J. & Liu, D. R. Prime editing for precise and highly versatile genome manipulation. Nat. Rev. Genet. 24, 161–177 (2023).
Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014).
Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
Kampmann, M. CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine. ACS Chem. Biol. 13, 406–416 (2018).